Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2006-10-24
2006-10-24
Steadman, David J. (Department: 1656)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S410000, C435S252300, C435S254110, C435S320100, C435S226000, C536S023200, C536S023500
Reexamination Certificate
active
07125715
ABSTRACT:
A novel polypeptide, a polynucleotide encoding this polypeptide, an expression vector comprising this polynucleotide, a cell transfected with the expression vector, and a pharmaceutical composition for promoting type II collagen production, a pharmaceutical composition for promoting aggrecan production, and a pharmaceutical composition for treating and/or preventing osteoarthritis comprising the above polypeptide as an active ingredient are disclosed. The polypeptide exhibits an activity of promoting type II collagen production and/or an activity of promoting aggrecan production.
REFERENCES:
patent: 6586390 (2003-07-01), Haley et al.
patent: WO 96/38168 (1996-12-01), None
patent: WO 98/51317 (1998-11-01), None
patent: WO 01/05825 (2001-01-01), None
patent: WO 01/05825 (2001-01-01), None
patent: WO 01/53456 (2001-07-01), None
patent: WO 01/53456 (2001-07-01), None
patent: WO 01/55437 (2001-08-01), None
Harrison et al. (1991) Exp Cell Res 192:340-345.
Adolphe et al. (1984) Exp Cell Res 155:527-536.
Branden et al. “Introduction to Protein Structure”, Garland Publishing Inc., New York, 1991, p. 247.
Witkowski et al. (1999) Biochemistry 38:11643-11650.
Dang et al. (1999) Clin Can Res 5:471-474.
Fox (2003) Nat Biotechnol 21:217.
Wozney et al. (1988) Science 242:1528-1534.
Sailor et al. (1996) J Orthop Res 14:937-945; abstract only.
European Search Report mailed Dec. 3. 2004, for European Patent Application No. 01997548.1, which is a national phase filing of PCT Application No. PCT/JP01/10150, filed Nov. 21, 2001.
Davis et al., Dec. 27, 1996, “Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning,” Cell, 87(7): 1161-1169.
Gerber et al., Jun. 1999, “VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation,” Nature Medicine, 5(6): 623-628.
Haigh et al., Mar. 7, 2000, “Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state,” Development, 127: 1445-1453.
Hänsch et al., Jun. 1995, “Matrix Protein Synthesis by Glomerular Mesangial Cells in Culture: Effects of Transforming Growth Factor β (TGFβ) and Platelet-Derived Growth Factor (PDGF) on Fibronectin and Collagen Type IV mRNA,” J. Cellular Physiology, 163(3):451-457.
Satoh et al., May 15, 1998, “Functional Analysis of Diastrophic Dysplasia Sulfate Transporter,” J. Biological Chemistry, 273(20): 12307-12315.
Astellas Pharma Inc.
Finnegan Henderson Farabow Garrett & Dunner LLP
Steadman David J.
LandOfFree
Nucleic acid encoding a polypeptide promoting type II... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid encoding a polypeptide promoting type II..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid encoding a polypeptide promoting type II... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3665527